Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...

The demand for GLP-1 medications is only increasing. As employees seek better health benefits, employers who act now will set ...

WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

A Big Chalk Analytics survey of 4,511 U.S. shoppers in spring of 2025 showed that 11.2% of adults are using GLP-1 drugs, and ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...

Rosie O’Donnell turned heads on the red carpet for her drastic weight loss.The 63-year-old had admitted to taking Mounjaro, ...

A breakthrough has been made in weight-loss drugs after scientists discovered a new medication – known as TDP – that works ...

West Pharmaceutical (NYSE:WST) surges after Q2 results beat estimates & full-year guidance rises. Read more here.

GLP-1 agonists and dual agonists can cause hypoglycemia, nausea, and more. But there are ways to lessen the side effects, so you can keep taking the medication.

CHICAGO — Tariffs, the rise of GLP-1 medications and concerns about ultra-processed foods (UPFs) remain some of the major ...